Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuan Yan

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
Cancer Cell International|August 31, 2023
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathwayGuang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, et al.
Biomarker Research|October 4, 2023
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patientsXin-Cheng Mao, Shuo Shi, Lun-Jie Yan, et al.
Science Advances|March 1, 2024
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapiesKushal Prajapati, Chuan Yan, Qiqi Yang, et al.
Food & Function|April 22, 2025
An umbrella review of the association between dietary factors and hepatocellular carcinoma riskHan Li, Qi-Hang Cao, Hui Liu, et al.
Metabolism: Clinical and Experimental|May 25, 2025
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune responseGuo-Qiang Pan, Yu-Chuan Yan, Rui-Zhe Li, et al.
The Oncologist|June 28, 2024
Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysisShi-Jia Liu, Lun-Jie Yan, Han-Chao Wang, et al.
Clinical & Experimental Metastasis|June 12, 2023
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysisBao-Wen Tian, Cheng-Long Han, Han-Chao Wang, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patientsCheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
Frontiers in Psychiatry|September 12, 2022
Factoring and correlation in sleep, fatigue and mental workload of clinical first-line nurses in the post-pandemic era of COVID-19: A multi-center cross-sectional studyYan Liu, Ji Shu Xian, Rui Wang, et al.
Journal of Gastroenterology and Hepatology|April 30, 2024
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysisQi-Hang Cao, Hui Liu, Lun-Jie Yan, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Cancer Cell International|August 31, 2023
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathwayGuang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, et al.
Biomarker Research|October 4, 2023
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patientsXin-Cheng Mao, Shuo Shi, Lun-Jie Yan, et al.
Science Advances|March 1, 2024
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapiesKushal Prajapati, Chuan Yan, Qiqi Yang, et al.
Food & Function|April 22, 2025
An umbrella review of the association between dietary factors and hepatocellular carcinoma riskHan Li, Qi-Hang Cao, Hui Liu, et al.
Metabolism: Clinical and Experimental|May 25, 2025
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune responseGuo-Qiang Pan, Yu-Chuan Yan, Rui-Zhe Li, et al.
The Oncologist|June 28, 2024
Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysisShi-Jia Liu, Lun-Jie Yan, Han-Chao Wang, et al.
Clinical & Experimental Metastasis|June 12, 2023
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysisBao-Wen Tian, Cheng-Long Han, Han-Chao Wang, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patientsCheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
Frontiers in Psychiatry|September 12, 2022
Factoring and correlation in sleep, fatigue and mental workload of clinical first-line nurses in the post-pandemic era of COVID-19: A multi-center cross-sectional studyYan Liu, Ji Shu Xian, Rui Wang, et al.
Journal of Gastroenterology and Hepatology|April 30, 2024
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysisQi-Hang Cao, Hui Liu, Lun-Jie Yan, et al.
Pageof 26